Skip to main content

TRAVERSE Trial

Meaning

TRAVERSE Trial is a large, randomized, placebo-controlled study assessing testosterone replacement therapy (TRT) cardiovascular safety in hypogonadal men. It investigated if TRT increases major adverse cardiovascular events (MACE) in men with existing cardiovascular disease or elevated risk. This trial provides definitive evidence regarding testosterone’s cardiac impact.
Porous, bone-like structures with smooth, integrated supports visualize foundational impacts. This symbolizes Hormone Replacement Therapy's HRT role in restoring cellular health, bone density, and systemic homeostasis. It highlights bioidentical hormones and peptide protocols for metabolic optimization and addressing hypogonadism.
What Are the Long-Term Implications of Combining Peptide Therapies with Hormonal Optimization for Cardiovascular Health?

What Are the Long-Term Implications of Combining Peptide Therapies with Hormonal Optimization for Cardiovascular Health?

Combining hormonal and peptide therapies aims to synergistically support long-term cardiovascular health by restoring systemic balance and promoting targeted cellular repair.



HRTio
July 24, 2025